Serum interleukin 17 levels in patients with Crohn's disease: Real life data

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Sahin, Abdurrahman ^a   Calhan, Turan ^b   Cengiz, Mustafa ^c   Kahraman, Resul ^d   Aydin, Kubra ^e   Ozdil, Kamil ^a   Korachi, May ^e   Sokmen, H Mehmet ^a  

^a Elazig Education and Research Hospital ^*  (Turkey)

^b Gastroenterology Department Turkiye Gazetesi Hospital   (Turkey)

^c ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d Batman Regional Government Hospital   (Turkey)

^e YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; HEMOGLOBIN; INTERLEUKIN 17; MESALAZINE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; THROMBOCYTE COUNT; ADOLESCENT; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED;

EID: 84926111427     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/690853     Document Type: Article

References (28)

1. C. Fiocchi, "Inflammatory bowel disease: etiology and pathogenesis, " Gastroenterology, vol. 115, no. 1, pp. 182-205, 1998.
2. N. A. Braus and D. E. Elliott, "Advances in the pathogenesis and treatment of IBD, " Clinical Immunology, vol. 132, no. 1, pp. 1-9, 2009.
3. S. Brand, "Crohns disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohns disease, " Gut, vol. 58, no. 8, pp. 1152-1167, 2009.
4. L. A. Tesmer, S. K. Lundy, S. Sarkar, and D. A. Fox, "Th17 cells in human disease, " Immunological Reviews, vol. 223, no. 1, pp. 87-113, 2008.
5. M. J. McGeachy, K. S. Bak-Jensen, Y. Chenet al. , "TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology, " Nature Immunology, vol. 8, no. 12, pp. 1390-1397, 2007.
6. M. Oukka, "Th17 cells in immunity and autoimmunity, " Annals of the Rheumatic Diseases, vol. 67, no. supplement 3, pp. iii26-iii29, 2008.
7. S. Romagnani, "Human Th17 cells, " Arthritis Research and Therapy, vol. 10, no. 2, article 206, 2008.
8. R. M. Onishi and S. L. Gaffen, "Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease, " Immunology, vol. 129, no. 3, pp. 311-321, 2010.
9. S. Fujino, A. Andoh, S. Bamba et al. , "Increased expression of interleukin 17 in inflammatory bowel disease, " Gut, vol. 52, no. 1, pp. 65-70, 2003.
10. M. Sarra, F. Pallone, T. T. MacDonald, and G. Monteleone, "IL-23/IL-17 axis in IBD, " Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1808-1813, 2010.
11. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen, "TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation, " Cytokine, vol. 56, no. 3, pp. 633-640, 2011.
12. W. R. Best, J. M. Becktel, J. W. Singleton, and F. Kern Jr. , "Development of a Crohns disease activity index. National cooperative Crohns disease study, " Gastroenterology, vol. 70, no. 3, pp. 439-444, 1976.
13. M. B. Frenz, P. Dunckley, L. Camporota, D. P. Jewell, and S. P. L. Travis, "Comparison between prospective and retrospective evaluation of Crohns disease activity index, " American Journal of Gastroenterology, vol. 100, no. 5, pp. 1117-1120, 2005.
14. M. Veny, M. Esteller, E. Ricart, J. M. Pique, J. Panes, and A. Salas, "Late Crohns disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients, " Alimentary Pharmacology andTherapeutics, vol. 31, no. 5, pp. 561-572, 2010.
15. M. Miletic, R. Stojanovic, O. Pajic et al. , "Seruminterleukin-17& nitric oxide levels in patients with primary Sjogrens syndrome, " Indian Journal of Medical Research, vol. 135, no. 4, pp. 513-519, 2012.
16. L. Zhao, Y. Tang, Z. You et al. , "Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression, " PLoS ONE, vol. 6, no. 4, Article ID e18909, 2011.
17. C. Yue, X. You, L. Zhao et al. , "The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients, " Rheumatology International, vol. 30, no. 12, pp. 1553-1557, 2010.
18. D. Y. Chen, Y. M. Chen, H. H. Chen, C. W. Hsieh, C. C. Lin, and J. L. Lan, "Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy, " Arthritis Research andTherapy, vol. 13, no. 4, article R126, 2011.
19. C. W. Lees, J. C. Barrett, M. Parkes, and J. Satsangi, "New IBD genetics: common pathways with other diseases, " Gut, vol. 60, no. 12, pp. 1739-1753, 2011.
20. T. S. Stappenbeck, J. D. Rioux, A. Mizoguchi et al. , "Crohn disease: a current perspective on genetics, autophagy and immunity, " Autophagy, vol. 7, no. 4, pp. 355-374, 2011.
21. F. Caprioli, F. Bose, R. L. Rossi et al. , "Reduction of CD68+ macrophages and decreased il-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlatewith endoscopic response andmucosal healing following infliximab therapy, " Inflammatory BowelDiseases, vol. 19, no. 4, pp. 729-739, 2013.
22. V. Holtta, P. Klemetti, H. M. Salo et al. , "Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis, " Journal of Pediatric Gastroenterology and Nutrition, vol. 57, pp. 287-292, 2013.
23. T. Kobayashi, S. Okamoto, T. Hisamatsu et al. , "IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohns disease, " Gut, vol. 57, no. 12, pp. 1682-1689, 2008.
24. E. Franze, R. Caruso, C. Stolfi et al. , "Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease, " PLoS ONE, vol. 8, no. 7, Article ID e69839, 2013.
25. M. Mohammadi, M. J. Zahedi, A. R. Nikpoor, M. R. Baneshi, and M. M. Hayatbakhsh, "Interleukin-17 serum levels and TLR4 polymorphisms in Ulcerative Colitis, " Iranian Journal of Immunology, vol. 10, no. 2, pp. 83-92, 2013.
26. D. Schwarzmaier, D. Foell, T. Weinhage, G. Varga, and J. Dabritz, "Peripheral monocyte functions and activation in patients with quiescent Crohns disease, " PLoS ONE, vol. 8, no. 4, Article ID e62761, 2013.
27. A. Ueno, H. Jijon, R. Chan et al. , "Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity betweenTh17 and regulatory T cells in inflammatory bowel disease patients, " Inflammatory Bowel Diseases, vol. 19, no. 2, pp. 2522-2534, 2013.
28. R. Pappu, V. Ramirez-Carrozzi, N. Ota, W. Ouyang, and Y. Hu, "The IL-17 family cytokines in immunity and disease, " Journal of Clinical Immunology, vol. 30, no. 2, pp. 185-195, 2010.